SynthesisPharmacoEconomics - open2022

Medical and Non-medical Costs of Sickle Cell Disease and Treatments from a US Perspective: A Systematic Review and Landscape Analysis.

Zachary Baldwin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.